Your home for biotech and planetary health insight and opinion.
Let's build rapport.
Showing the math: How IRA destoys NPV
Understanding how investors use NPV to value drugs at various stages of drug development explains what CBO's and other analyses miss.
*Keep me informed! I understand I’m opting into letting the RA Capital team contact me, which is totally fine cause they aren’t boring.